SYK and cancer: Once FcγRs on immune cells bind to antibody-coated cancer cells, a signaling cascade is triggered, involving immunoreceptor tyrosine-based activation motifs (ITAMs) and spleen tyrosine kinase (Syk) which enable the immune cell to engulf and degrade the cancer cell [22, 31].